← Leaderboards
Mayumi Nakagawa
University Of California San Francisco
$10,306,321
Attributed
$10,306,321
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $774.8K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,306,321 · 2
By mechanism
R01$10,048,741 · 1
K07$257,580 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Katherine Kurshan Matthay$7,757,759
- James L. Sorensen$27,892,556
- Frank Patrick McCormick$56,513,144
- Diane W. Wara$7,985,315
- John Kurhanewicz$27,913,734
Others in their field
Top investigators on “Human Papillomavirus”
- Ronald T Mitsuyasu · University Of California Los Angeles$106,431,894
- Leonard Freedman · Leidos Biomedical Research, Inc.$53,948,093
- Kathryn M Anastos · Montefiore Medical Center (Bronx, Ny)$50,130,116
- Paula Gonzalez-Maya · Fundacion Inciensa$38,145,031
- David Heimbrook · Leidos Biomedical Research, Inc.$33,306,253
- Paul F Lambert · University Of Wisconsin Madison$31,091,618
Research focus
Human PapillomavirusVaccinesCandidaTherapeutic VaccineSquamous Intraepithelial LesionSafetyMalignant NeoplasmsPreventPhase I Clinical TrialsPhase Ii Clinical TrialsImmune ResponseProteinsCancer EtiologyResponseT Cell ResponseAdjuvantMalignant Neoplasm Of Cervix UteriHigh RiskCervicalOperative Surgical ProceduresBiopsyT-LymphocyteDoseWoman
Grant awards (18)
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal$727,264
R01 · FY2025 · CA · contact PI
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal$690,909
R01 · FY2024 · CA · contact PI
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal$727,275
R01 · FY2023 · CA · contact PI
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal$712,726
R01 · FY2022 · CA · contact PI
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal$727,272
R01 · FY2021 · CA · contact PI
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses$721,276
R01 · FY2020 · CA · contact PI
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses$699,636
R01 · FY2019 · CA · contact PI
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses$721,272
R01 · FY2018 · CA · contact PI
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses$721,274
R01 · FY2017 · CA · contact PI
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses$545,019
R01 · FY2016 · CA · contact PI
Understanding and Enhancing T-Cell Responses to high Risk Human Papillomaviruses$476,773
R01 · FY2014 · CA · contact PI
Understanding and Enhancing T-Cell Responses to high Risk Human Papillomaviruses$464,563
R01 · FY2013 · CA · contact PI
Understanding and Enhancing T-Cell Responses to high Risk Human Papillomaviruses$639,225
R01 · FY2012 · CA · contact PI
Understanding and Enhancing T-Cell Responses to high Risk Human Papillomaviruses$699,449
R01 · FY2011 · CA · contact PI
Understanding and Enhancing T-Cell Responses to high Risk Human Papillomaviruses$774,808
R01 · FY2010 · CA · contact PI
CYTOTOXIC T LYMPHOCYTE RESPONSE TO HPV 16$85,860
K07 · FY2002 · CA
CYTOTOXIC T LYMPHOCYTE RESPONSE TO HPV 16$85,860
K07 · FY2001 · CA
CYTOTOXIC T LYMPHOCYTE RESPONSE TO HPV 16$85,860
K07 · FY2000 · CA